Overall these results predict that HDAC inhibition will promote excitation and network activity, which could be beneficial in cases of cognitive impairment featuring weakened synaptic function, reduced synaptic potentiation, and loss of excitatory synapse, as is the case in mouse models of AD. This evidence concerns the gene HDAC9 and Alzheimer disease.